In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2635-2637

  Capilla, J ^a   Ortoneda, M ^a   Pastor, F J ^a   Guarro, J ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CHAETOMIUM; DILUTION; FUSARIUM SOLANI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPPORTUNISTIC INFECTION; PAECILOMYCES LILACINUS; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; FUSARIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; PAECILOMYCES; QUINAZOLINES; TRIAZOLES;

EID: 0034863773     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2635-2637.2001     Document Type: Article

References (19)

1. Antifungal susceptibilities of Paecilomyces species
2. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient
3. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones
4. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections
5. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
6. In vitro antifungal susceptibility of nondermatophytic keratinophilic fungi
7. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani
8. Pathogenicity and antifungal susceptibility of Chaetomium species
9. Paecilomyces sinusitis in an immunocompromised adult patient: Case report and review
10. Opportunistic mycotic infection caused by Chaetomium in a patient with acute leukemia
11. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
12. Onychomycosis caused by Chaetomium globosum Kunze
13. In vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains
14. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi
15. In vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp
16. Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management
17. Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: Case report and review